Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anika Therapeutics

14.74
+0.25001.73%
Post-market: 14.740.00000.00%16:05 EDT
Volume:35.55K
Turnover:525.81K
Market Cap:211.39M
PE:-3.85
High:15.04
Open:14.51
Low:14.51
Close:14.49
Loading ...
May 08, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Major Issues Report

8-K - Current report
Apr 29, 2020

Major Issues Report

Current report, items 1.01, 5.02, 7.01, and 9.01
Apr 08, 2020

Major Issues Report

Current report, items 2.03 and 9.01
Mar 13, 2020

Major Issues Report

8-K/A [Amend] - Current report
Mar 13, 2020

Major Issues Report

8-K/A [Amend] - Current report
Mar 06, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

Current report, items 5.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 04, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 03, 2020

Major Issues Report

Current report, items 2.01, 8.01, and 9.01
Jan 30, 2020

Major Issues Report

Current report, items 5.02, 7.01, and 9.01
Jan 24, 2020

Major Issues Report

Current report, items 2.01, 8.01, and 9.01
Jan 07, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Jan 06, 2020

Major Issues Report

Current report, items 8.01 and 9.01